Teladoc Stock: Huge Execution Problem (NYSE:TDOC)

Morsa Images/DigitalVision via Getty Images The strong rally on the stock markets since 2023 has also led to a solid stabilization of share prices for many former high-flyers. Normalized expectations met with an increasing risk appetite among investors. This was not the case with Teladoc (NYSE:TDOC): the share was unable to benefit from this in…

Read More

Travelzoo: Business Model Transformation With Considerable Execution Risk (NASDAQ:TZOO)

den-belitsky Introduction and thesis Travelzoo (NASDAQ:TZOO) is a global media commerce company that provides insider deals and experiences for members through its website, email newsletters, social media channels, and mobile apps. The company offers discounted deals on travel, entertainment, dining, and other lifestyle activities, partnering with thousands of travel and entertainment companies worldwide. We are…

Read More

Citigroup Stock Turnaround Story May Finally Be Here – Execution Remains Critical (NYSE:C)

Frank Armstrong/iStock via Getty Images We previously covered Citigroup Inc. (NYSE:C) in October 2023, discussing its crown jewel’s promising performance, TTS, with it being the fastest-growing business, well exceeding the previous Investor Day revenue CAGR target of high single digits. While this outperformance had yet to be translated to its bottom line as it also…

Read More

Alphatec Holdings: Taking Market Share Amid Strong Execution – Buy (NASDAQ:ATEC)

Natali_Mis Note: I have discussed Alphatec Holdings, Inc. (NASDAQ:ATEC) previously, so investors should view this article as an update to my earlier coverage of the company. Introduction / Discussion Of Past Performance Alphatec Holdings, Inc. or “ATEC” is a medical technology company that designs, develops, and advances technologies for the surgical treatment of spinal disorders….

Read More

Ameresco: The Delayed Execution Of Projects Resulting In Subdued Performance (NYSE:AMRC)

ArtistGNDphotography Investment Thesis Ameresco, Inc. (NYSE:AMRC) is an American energy infrastructure and solutions provider headquartered in Framingham, Massachusetts. In this thesis, I will analyze the third-quarter results of AMRC and its future growth prospects. I will also be analyzing its valuation at the current price level and its upside potential. I believe the company has…

Read More

Paycor: Solid Execution Priced In (NASDAQ:PYCR)

vinnstock Investment Thesis Paycor HCM (NASDAQ:PYCR) had been affected due to a risk-off sentiment as macro slowdown makes the SMB segment, its core focus, more susceptible along with slowing employment growth. However, we really like the strong execution and follow through on earnings momentum in a challenging macro environment with stable retention ratios and strong…

Read More

Gorman-Rupp: Good Execution, Steep Price (NYSE:GRC)

imantsu The Gorman-Rupp Company (NYSE:GRC) sells pump systems to multiple industries. The company has completed the acquisition of Fill-Rite in 2022, fueling the company for better margins and revenue growth through growth synergies. The company has executed well after the acquisition with good growth in Q3 along with strong margins. Still, the stock doesn’t seem…

Read More

Linde Q3: Stellar Execution Despite Macro Weakness

audioundwerbung I have recently initiated coverage of Linde plc (NYSE:LIN) in which I described my general thesis behind the company (Linde: Best Of Breed Defensive Growth Plus Hydrogen Upside Make It A Buy) and outlined some key points of interest that I advise investors to monitor over the next quarters. On October 26, Linde released…

Read More

Twist Bioscience Stock: Progress Hidden By Execution Issues And Soft Demand (NASDAQ:TWST)

ebrublue10 Twist Bioscience (NASDAQ:TWST) is slowly making progress in its core SynBio and NGS businesses, but its Biopharma business has execution issues and investment in data storage is being scaled back, potentially delaying commercialization. A greater focus on costs is leading to an improvement in margins, which should continue into FY2024 as production at the…

Read More